"Busy Man" Zhao Chunquan
Release time:
2020-08-14
Zhao Chunquan, entered Jianfeng Pharmaceutical Company in 8# May 2009 , and entered Jianfeng Health Technology Company in 2014 . He is currently the director of Jianfeng Health Plant Extraction Workshop and the director of Chinese Herbal Pieces Workshop.
"Busy Man" Zhao Chunquan
Zhao Chunquan is a busy man. He plunges into the workshop site as soon as he goes to work every day, and it is difficult to find him in the office. When he finally saw him after an "appointment", he was covered with yellow powder and joked with a smile that "I just came back from work on the construction site". In fact, he had been busy in the Chinese herbal medicine workshop for a long time.
Zhao Chunquan has been busy since he took part in the work-entered the factory, 9 participated in the preparation of the plant medicine factory, responsible for the installation, debugging and trial production of the equipment, followed by the pharmaceutical health care product workshop, the peak health Chinese medicine decoction pieces and the plant extraction workshop. In the past few years of peak work, a workshop was basically built. He used to participate in debugging, trial production, straightened out and handed over, and then started a new project.
has gone through debugging, trial production and certification work in several workshops. Zhao Chunquan is also experienced, but he said that the busiest is the newly-built automatic extraction workshop. Everything is new, the new equipment is more advanced, the production process is new, there are many things to learn, and besides the study of hardware equipment, they should also be familiar with computer operation. The newly recruited employees in the workshop basically have no experience in drug production. They should not only teach equipment operation, but also teach labor discipline, GMP knowledge, safety production, etc, all this work is on him.
2015 12# In mid-April, the planting workshop entered the equipment commissioning stage. Zhao Chunquan first followed the manufacturer's personnel to learn the equipment operation one by one. The whole workshop is expected to have 170 sets of equipment. In order to ensure the smooth progress of the follow-up work, it can only be carried out overtime. During that half a month, there was no lunch break or weekend, and finally the debugging was completed at the end of the month.
20 minutes to explain the operation precautions and other contents, so that employees can master the operation skills faster and better. During the period of
12 hours a day. Generally, he came to work more than 7 at night. After arranging the workshop in the morning, he went back from work more than 10 . If he encounters equipment failure or production process problems, he can only stay and squint against the back of the chair for a while when he is sleepy. He said that at most, he worked for three days and two nights in a row. Sometimes I get off work on time during the day, and when I have a problem with the night shift, I have to rush back to the workshop in the early morning to deal with it. After the
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31